NCT00761670 Efficacy Study on Cognitive Functions in Schizophrenic Patients Status COMPLETED Phase PHASE4
NCT00761605 Phase 4 Study to Evaluate Efficacy of Paliperidone Extended-Release(ER) in Schizophrenic Participants Status COMPLETED Phase PHASE4
NCT00761579 Paliperidone Extended Release(ER) Effectiveness Study to Evaluate the Objective Symptom Change and Symptomatic Remission Status COMPLETED Phase PHASE4
NCT00761189 PaliperidoNe Extended-Release [ER] Dosing and Clinical Response in Acute Schizophrenia Status COMPLETED Phase PHASE4
NCT00759460 Study on Metabolic Parameters of Sertindole in Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT00759421 Exploratory Cognition Study of Sertindole in Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT00758251 Observation of Change in Clinical Global Impression Scores in Schizophrenia Patients Receiving Seroquel XR Treatment Status COMPLETED Phase N/A
NCT00758030 Study Evaluating and Comparing Single Dose and Multiple Dose Pharmacokinetics of ER OROS Paliperidone in Healthy Japanese and Caucasian Adults. Status COMPLETED Phase PHASE1
NCT00757978 Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms Status COMPLETED Phase PHASE4
NCT00757705 An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended-Release (ER) in Participants With Schizophrenia Status COMPLETED Phase PHASE4
NCT00757497 Transcranial Direct Current Brain Stimulation to Treat Patients With Childhood-Onset Schizophrenia Status TERMINATED Phase PHASE1
NCT00753051 Treat Clozapine ( CLZ )-Resistant Schizophrenia Comparing CLZ + Haloperidol vs. CLZ + Electroconvulsive Therapy (ECT) Status COMPLETED Phase NA
NCT00752427 24-Week Open Label Extension to a Randomized, 6-Week Double Blind, Placebo Controlled Study, to Evaluate the Safety and Tolerability of Flexible Doses of Extended Release OROS® Paliperidone in the Treatment of Geriatric Subjects With Schizophrenia Status COMPLETED Phase PHASE3
NCT00750087 Non-interventional Study -Observe Treatment Efficacy in Maintaining Symptoms Control in Schizophrenia With Seroquel XR Status COMPLETED Phase N/A
NCT00749970 Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia Status COMPLETED Phase N/A
NCT00743847 A 6-Week Multicenter Trial Of Varenicline Tartrate For Cognitive Impairment In Subjects With Schizophrenia Status WITHDRAWN Phase PHASE2
NCT00742079 Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for Schizophrenia Status COMPLETED Phase PHASE4
NCT00740259 Efficacy and Tolerability of Flunarizine for the Treatment of Schizophrenia: Comparison With Haloperidol Status COMPLETED Phase PHASE4
NCT00737256 A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence Status UNKNOWN Phase PHASE2